Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH6309D
- Pages: 27
- November 2018
- Total Views:1267
- Region : North America
- GlobalData
- Equity Research Report

Details
Summary
Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.
Apotex Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12
Merger 14
Apotex to Merge with Strides Shasun 14
Licensing Agreements 15
Panacea Biotec Expands Licensing Agreement with Apotex 15
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17
Asset Transactions 19
Aurobindo Pharma to Acquire Generics Business of Apotex 19
Acquisition 20
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20
Apotex Inc-Key Competitors 21
Apotex Inc-Key Employees 22
Apotex Inc-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Government and Public Interest 25
Mar 08, 2018: Advisory-Chipped pills in additional packages of Alysena 21 and 28 birth control pills 25
Other Significant Developments 26
Mar 08, 2017: Apotex Announces USD 184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company's Largest Investment in the United States 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List Of Figure
List of Figures
Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apotex Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12
Apotex to Merge with Strides Shasun 14
Panacea Biotec Expands Licensing Agreement with Apotex 15
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17
Aurobindo Pharma to Acquire Generics Business of Apotex 19
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20
Apotex Inc, Key Competitors 21
Apotex Inc, Key Employees 22
Apotex Inc, Subsidiaries 23
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Company Profile
Company Profile Title
Summary
Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.
Apotex Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12
Merger 14
Apotex to Merge with Strides Shasun 14
Licensing Agreements 15
Panacea Biotec Expands Licensing Agreement with Apotex 15
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17
Asset Transactions 19
Aurobindo Pharma to Acquire Generics Business of Apotex 19
Acquisition 20
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20
Apotex Inc-Key Competitors 21
Apotex Inc-Key Employees 22
Apotex Inc-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Government and Public Interest 25
Mar 08, 2018: Advisory-Chipped pills in additional packages of Alysena 21 and 28 birth control pills 25
Other Significant Developments 26
Mar 08, 2017: Apotex Announces USD 184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company's Largest Investment in the United States 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List Of Figure
List of Figures
Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apotex Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Apotex Inc, Medical Devices Deals, 2012 to YTD 2018 10
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Charterhouse Capital Partners Acquires Doc Generici For USD 424 Million 12
Apotex to Merge with Strides Shasun 14
Panacea Biotec Expands Licensing Agreement with Apotex 15
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 16
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 17
Aurobindo Pharma to Acquire Generics Business of Apotex 19
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 20
Apotex Inc, Key Competitors 21
Apotex Inc, Key Employees 22
Apotex Inc, Subsidiaries 23
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company